<code id='70FBA555CB'></code><style id='70FBA555CB'></style>
    • <acronym id='70FBA555CB'></acronym>
      <center id='70FBA555CB'><center id='70FBA555CB'><tfoot id='70FBA555CB'></tfoot></center><abbr id='70FBA555CB'><dir id='70FBA555CB'><tfoot id='70FBA555CB'></tfoot><noframes id='70FBA555CB'>

    • <optgroup id='70FBA555CB'><strike id='70FBA555CB'><sup id='70FBA555CB'></sup></strike><code id='70FBA555CB'></code></optgroup>
        1. <b id='70FBA555CB'><label id='70FBA555CB'><select id='70FBA555CB'><dt id='70FBA555CB'><span id='70FBA555CB'></span></dt></select></label></b><u id='70FBA555CB'></u>
          <i id='70FBA555CB'><strike id='70FBA555CB'><tt id='70FBA555CB'><pre id='70FBA555CB'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:8
          A person walks past the Palantir sign. -- health tech coverage from STAT
          FABRICE COFFRINI/AFP via Getty Images

          PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services. 

          Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools. 

          advertisement

          For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Setback for rare diseases as Taysha Gene Therapies pulls back
          Setback for rare diseases as Taysha Gene Therapies pulls back

          AdobeIn2020,asbiotechstockssurgedamidthepandemic,astartupcalledTayshaGeneTherapiesraisedover$300mill

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          The Karikó problem: Lessons for funding basic research

          AdobeNewscientificinstitutesarespringingupallovertheplacethesedays:ArcadiaScience,NewScience,ArcInst